← Back to all trials
Recruiting
NCT07843615
Mechanism of BCI-Based Dual-Target Neurofeedback Training in Improving Cognitive Control Deficits in Internet Gaming Disorder
Conditions: Internet Gaming Disorder
Sex: All
Ages: 18 Years – 35 Years
Healthy volunteers: No
Phase: NA
Enrollment: 120
Sponsor: The First Affiliated Hospital of Bengbu Medical University
Location: Bengbu Medical University Bengbu
Summary
Addressing the three core issues in research on cognitive control deficits in Internet Gaming Disorder (IGD)-unclear neural mechanisms, limited intervention targets, and poor patient compliance-this project innovatively constructs a pathological model of IGD characterized by "decline in social rewards → dysfunction of the dorsal Anterior Cingulate Cortex-Dorsolateral Prefrontal Cortex (dACC-DLPFC) cognitive control circuit → abnormalities in the frontal midline theta rhythm (Fmθ)." The investigators have developed a dual-target intervention system that integrates neurofeedback with social reward substitution, transforming social rewards into therapeutic reinforcers to enhance the effectiveness of the intervention.
Eligibility Criteria
Inclusion Criteria:
* Individuals aged between 18 and 35 years, irrespective of gender, having completed a minimum of 9 years of education and capable of effectively cooperating in questionnaire evaluations
* Consent to actively cooperate in the completion of subsequent follow-up assessments
* Right-handed
* The Gaming Disorder Screening (GDSS) Scale score ≥ 47 points
* Average weekly gaming time greater than 21 hours, maintained for over one year
* More than 50% of daily internet time spent playing online games
Exclusion Criteria:
* Severe cognitive functional impairments manifested through a history of head trauma, cerebrovascular diseases, epilepsy, etc., or usage of cognitive enhancement drugs in the past 6 months
* Left-handed
* An intellectual disability with an IQ score less than 70
* A diagnosis of schizophrenia or other severe mental illnesses as per the DSM-5 criteria
* Abuse or dependence on other psychoactive substances (excluding nicotine) within the past 5 years
* Severe organic diseases that might compromise study participation
* Color blindness or color weakness
Source: ClinicalTrials.gov (NCT07843615). StuddyBuddy aggregates publicly available trial information.